Epidemiology and natural history of nephrolithiasis

Clinical Reviews in Bone and Mineral Metabolism

Volumn 9, Issue 3-4, 2011, Pages 165-180

  Wasserstein, Alan G ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diet and kidney stones; Epidemiology of kidney stones; Hypercalciuria; Hyperoxaluria; Hyperuricosuria; Hypocitraturia; Kidney stones; Natural history of kidney stones; Risk factors for kidney stones

Indexed keywords

ALLOPURINOL; ASCORBIC ACID; CALCIUM; CITRIC ACID; FISH OIL; OXALIC ACID; PHOSPHORUS; PHYTATE; PYRIDOXINE; VITAMIN D;

APPLE JUICE; ATHEROSCLEROSIS; BARIATRIC SURGERY; BEVERAGE; CALCIUM INTAKE; CARBOHYDRATE INTAKE; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; DNA POLYMORPHISM; EXTRACORPOREAL LITHOTRIPSY; FAMILY HISTORY; FLUID INTAKE; FRUIT; GOUT; GRAPEFRUIT JUICE; HORSESHOE KIDNEY; HUMAN; HYPERTENSION; HYPERURICOSURIA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MEDULLARY SPONGE KIDNEY; METABOLIC SYNDROME X; MULTIFACTORIAL INHERITANCE; NEPHROLITHIASIS; OBESITY; OBSTRUCTIVE UROPATHY; OCCUPATION; OSTEOPENIA; POTASSIUM INTAKE; PREVALENCE; PYONEPHROSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK FACTOR; SALT INTAKE; SEASON; STAGHORN STONE; STONE FORMATION; SYSTEMIC DISEASE; VEGETABLE;

EID: 84855888046     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-011-9097-3     Document Type: Review

References (153)

1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141-52.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM Jr, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23. (Pubitemid 36513328)
3. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287-93. (Pubitemid 47189600)
4. Soucie JM, Thun MJ, Coates RJ, McClennan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893-9. (Pubitemid 24272050)
5. Ramello A, Vitale C, Marangella M. Epidemiology of nephro-lithiasis. J Nephrol. 2000;13(suppl 3):S45-50.
6. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86-96.
7. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 and 2000. Eur Urol. 2003;44:709-13. (Pubitemid 37542929)
8. Akoudad S, Szklo M, McAdams MA, Fulop T, Anderson CA, Coresh J, Kottgen A. Correlates of kidney stone disease differ by race in a multi-ethnic middle aged population: the ARIC Study. Prev Med. 2010;51:416-20.
9. Lieske JC, de la Pena Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69:760-4. (Pubitemid 43237647)
10. Jr Scales Cd, Curtis LH, Norrias RD, Springhart P, Sur RL, Shulman KA, Preminger GM. Changing gender prevalence of stone disease. J Urol. 2007;177:979-82. (Pubitemid 46216342)
11. Soucie JM, Coates RJ, McClellan W, Austin H, Thun M. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epid. 1996;143:487-95. (Pubitemid 26085079)
12. Blacklock NJ. The pattern of urolithiasis in the Royal Navy. In Hodgkinson A, Nordin BE, eds. Renal stone research symposium. London: Churchill 1969;33-47.
13. Pugliese JM, Baker KC. Epidemiology of nephrolithiasis in personnel returning fromn Operation Iraqi Freedom. Urology. 2009;74:56-61.
14. Parry ES, Lister IS. Sunlight and hypercalciuria. Lancet. 1975;10:1063-5.
15. Elomaa I, Karonen SL, Kairento AL, Pelkonen R. Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation. Scand J Urol Nephrol. 1982;16:155-61. (Pubitemid 12051258)
16. Fakheri RJ, Goldfarb D. Association of nephrolithiasis prevalence rates with ambient temperature in the United States: a re-analysis. Kidney Int. 2009;76:798.
17. Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci. 2008;105:9841-6. (Pubitemid 352031387)
18. Coe F, Keck J, Norton ER. The natural history of calcium nephrolithiasis. JAMA. 1977;238:1519-23.
19. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol. 1984;56:122-4. (Pubitemid 14128928)
20. Ahlstrand C, Tisleius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol Res. 1990;18:397-9.
21. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999;162: 27-30. (Pubitemid 29420872)
22. Pak CY. Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol. 1982;127:855-8. (Pubitemid 12124233)
23. Hosseini MM, Eshragian A, Dehghanian I, Irani D, Amini M. Metabolic abnormalities in patients with nephrolithiasis: comparison with of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol. 2010;42:127-31.
24. Yagisawa T, Chandhoke PS, Fan J. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urol. 1998;52:750-5. (Pubitemid 28489693)
25. Glowacki LS, Beecroft ML, Cook RJ, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. 1992;147: 319-21.
26. Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534-9. (Pubitemid 39142114)
27. Inci K, Sahin A, Islamoglu E, Eren MT, Bakkaloglu M, Ozen H. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J Urol. 2007;177:2189-92. (Pubitemid 46726420)
28. Keeley FX Jr, Tilling K, Elves A, Menezes P, Wills P, Rao N, Fenely R. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. B JU Int. 2001;87:1-8.
29. Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol. 1976;115:505-6.
30. Rous SN, Turner WR. Retrospective study of 95 patients with staghorn calculus disease. J Urol. 1977;118:902-4. (Pubitemid 8261145)
31. Vargas AD, Bragin SD, Mendez R. Staghorn calculus: its clinical presentation, complications, and management. J Urol. 1982; 127:860-2. (Pubitemid 12124235)
32. Keoghane S, Walmsley B, Hodgson D. The natural history of untreated renal tract calculi. BJU Int. 2010;105:1627-31.
33. Candau C, Saussine C, Lang H, Roy C, Faure F, Jacqmin D. Natural history of residual renal stone fragments after ESWL. Eur Urol. 2000;37:18-22. (Pubitemid 30072368)
34. Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B, Anselmo G. Frammenti residui clinicamente insig-nificanti (CIRF) dopo litotrissia extracorporea: implicazioni e trattamento. J Urol. 1994;151:5-9.
35. Mollerup CL, Lindewald H. Renal stones and primary hyper-parathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg. 1999;23:173-5.
36. Better OS, Shabtai M, Kedar S, Melamud A, Berenheim J, Chaimovitz C. Increased incidence of nephrolithiasis in lifeguards in Israel. Adv Exp Med Biol. 1980;128:467-72.
37. Atan L, Andreoni C, Ortiz V, Silva EK, Pitta R, Atan F, Srougi M. High kidney stone risk in men working in steel industry at hot temperatures. Urology. 2005;65:858-61. (Pubitemid 40692970)
38. Borghi L, Meschi T, Amato F, Novarini A, Romanelli A, Cigala F. Hot occupation and nephrolithiasis. J Urol. 1993;150: 1757-60. (Pubitemid 24350791)
39. Chauhan V, Eskin B, Allegra JR, Cochrane DG. Effect of season, age, and gender on renal colic incidence. Am J Emerg Med. 2004;22:560-3. (Pubitemid 40143237)
40. Cervellin G, Comelli I, Comelli D, Cortellini P, Lippi G, Meschi T, Borghi L. Regional short-term climate variations influence on the number of visits for renal colic in a large urban emergency department: results of a 7-year survey. Intern Emerg Med. 2011;6:141-7.
41. Baker PW, Covie P, Bais R, Rofe AM. Influence of season, age, and sex on renal stone formation in South Australia. Med J Aust. 1993;159:390-2. (Pubitemid 23318799)
42. al-Hydramy MS. Seasonal variations of urinary stone colic in Arabia. J Pak Med Assoc. 1997;47:281-4.
43. Vezzoli G, Terranegra A, Arcidiacono T, Soldati L. Genetics and calcium nephrolithiasis. Kidney Int 2010;epub ahead of print, Accessed 5/26/2011.
44. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8: 1568-73. (Pubitemid 27496475)
45. Edvardsson VO, Palsson R, Indradason OS, Thorvaldsson S, Steffanson K. Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol. 2009;43:420-4.
46. Koyuncu H, Yencilek F, Eryildirim B, Sarica K. Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence? Urol Res. 2010;38:105-9.
47. Basiri A, Shakhssalim N, Khoshdel AR, Javaherforooshzadeh A, Basiri H, Radfar MH, Dorraj N. Familial relations and recurrence pattern in nephrolithiasis. Urol J. 2010;7:81-6.
48. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979;300:337-40. (Pubitemid 9114886)
49. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terra-negra A, Falchetti A, Cusi D, Bianchi G, Brandi ML. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002;13:2517-23.
50. Ferreira LG, Pereira AC, Heilberg IP. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients. Nephron Clin Pract. 2010; 114:c135-44.
51. Thorleifsson G, Holm H, Edvardsson V, et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet. 2009;412:926-30.
52. Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993;22:513-9. (Pubitemid 23308959)
53. Fick GM, Gabow PA. Hereditary and acquired cystic disease of the kidney. Kidney Int. 1994;46:951-64. (Pubitemid 24319931)
54. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008;17:304-9. (Pubitemid 351535934)
55. Robertson WG, Peacock M, Baker M, Marshall DH, Pearlman B, Speed R, Sergeant V, Smith A. Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol. 1983;55:595-8. (Pubitemid 14203896)
56. Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A. Essential arterial hypertension and stone disease. Kidney Int. 1999;55:2397-406. (Pubitemid 29256494)
57. Krambeck AE, Rule AD, Li X, Bergstrath EJ, Gettman MT, Lieske JC. Shock wave lithotripsy is not predictive of hypertension among community stone formers at long-term followup. J Urol. 2011;185:164-9.
58. Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Am Soc Nephrol. 1998; 9:1645-52. (Pubitemid 28405072)
59. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-62.
60. Semins M, Shore AD, Makary MA, Magnuson T, Johns R, Matiaga BR. The association of increasing body mass index and kidney stone disease. J Urol. 2010;183:571-5.
61. Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res. 2008;36:303-7.
62. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905-15. (Pubitemid 44895373)
63. Eisner BH, Eisenberg ML, Stoller ML. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology. 2010;75:1289-93.
64. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230-5. (Pubitemid 43246441)
65. Weikert C, Weikert S, Schulze MB, Pischon T, Fritsche A, Bergmann MM, Willich SN, Boeing H. Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epid. 2010;171:447-54.
66. West B, Luke A, Durazzo-Arvizo RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis. 2008;51:741-7. (Pubitemid 351626247)
67. Reiner AP, Kahn A, Eisner BH, et al. Kidney stones and sub-clinical atherosclorosis in young adults: the CARDIA study. J Urol. 2011;185:920-5.
68. DrFronzo R, Cooke CR, Andres CR, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845-55.
69. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolilthiasis in men: the health professionals' follow-up study. Kidney Int. 2003;64: 1022-6. (Pubitemid 37013838)
70. Rule AD, Roger VL, Melton LJ III, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21:1641-4.
71. Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004;171:1024-920.
72. Teichman JM, Long RD, Hulbert RC. Long-term renal fate and prognosis after staghorn calculus management. J Urol. 1995; 153:1403-7.
73. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis. 2004;44:799-805. (Pubitemid 39445911)
74. Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804-11.
75. Saucier NA, Sinha MK, Liang KV, et al. Risk factors for CKD in persons with kidney stones: a case-control study in Olmstead County, Minnesota. Am J Kidney Dis. 2010;55:61-8.
76. Marangella M, Bruno M, Cosseddu D, Manganaro M, Tricerri A, Vitale C, Linari F. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron. 1990;54: 302-6. (Pubitemid 20097870)
77. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Intl. 2007;71:1000-7.
78. Patel BN, Passman CM, Fernandez A, Asplin JR, Coe FL, Lingeman JE, Assimos DG. Prevalence of hyperoxaluria after modern bariatric surgery. J Urol. 2008;181:161-6.
79. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-8. (Pubitemid 23084337)
80. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497-504. (Pubitemid 27143627)
81. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women. Arch Intern Med. 2004;164:885-91. (Pubitemid 38520630)
82. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225-532.
83. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol 4;1980-1987.
84. Norman DA, Fordtran LJ, Brinkley LJ, Zerwekh JE, Nicar MJ, Strowig SM, Pak CY. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1, 25-dihydroxyvitamin D. J Clin Invest. 1981;67:1599-603. (Pubitemid 11127548)
85. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346: 77-84. (Pubitemid 34438897)
86. Heller HJ, Doerner MF, Brinkley LJ, Adams-Huet B, Pak CY. Effect of dietary calcium on stone forming propensity. J Urol. 2003;169:470-4. (Pubitemid 36132964)
87. Wallace RB, Wactawski-Wende O'Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K. Urinary tract stone occurrence in the women's health initiative randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 2011; April 27 (epub ahead of print).
88. Taylor EN, Curhan GC. Oxalate intake and the risk for neph-rolithiasis. J Am Soc Nephrol. 2007;18:2198-204.
89. Holmes PR, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59: 270-6. (Pubitemid 32055235)
90. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol. 1999;2(suppl 14):S329-33. (Pubitemid 29498574)
91. Lieske JC, Tremaine WJ, DeSimone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb D. Diet, not not oral probiotics, effectively reduces urine oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010;78:1178-11185.
92. Wasserstein AG. Lessons in medical humanism: the case of Montaigne. Ann Intern Med. 2007;146:809-13. (Pubitemid 351650501)
93. Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci. 1997; 9(57):285-8.
94. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66:140-6. (Pubitemid 18027743)
95. Robertson WG, Peacock M, Heyburn PJ, Hanes FA. Epidemi-ological risk factors in calcium stone disease. Scand J Urol Nephrol. 1980;53(suppl):15-30.
96. Peacock M, Nordin BEC. Hypercalciuria of renal stone disease. In Hodgkinson, A, Nordin BEC., eds. Proceedings of the renal stone research symposium. London: Livingtons, 1969;253-261.
97. O'Dwyer JT. Health aspects of vegetarian diets. Am J Clin Nutr. 1988;48:712-38.
98. Wasserstein AG, Stolley PD, Soper KA, Goldfarb S, Maislin G, Agus Z. A case-control study of risk factors for idiopathic calcium nephrolithiasis. Mineral Elect Metab. 1987;13:85-95. (Pubitemid 17081329)
99. Graces F, Costa-Bauza A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res. 1999;19:3717-22.
100. Graces F, Garcia-Gonzales R, Torres JJ, Llobera A. Effects of phytic acid on renal stone formation in rats. Scand J Urol Nephrol. 1998;32:261-5. (Pubitemid 28387176)
101. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009; 20:2253-9.
102. Taylor EN, Stampfer MJ, Mount DB, Curhan GC. DASH-style diet and 24-hour urine composition. Clin J Am Soc Nephrol. 2010;5:2315-22.
103. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402-10.
104. Taylor EN, Curhan GC. Role of nutrition in the formation of calcium-containing kidney stones. Nephron Physiol. 2004;98: 55-63.
105. Ebisuno S, Morimoto S, Yasukawa S, Ohkawa T. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients. Br J Urol. 1991;67:237-40.
106. Massey LK, Whiting SJ. Dietary salt, urinary calcium, and kidney stone risk. Nutr Rev. 1995;53:131-9.
107. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993;150:310-2. (Pubitemid 23215857)
108. Stoller ML, Chi T, Eisner BH, et al. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol. 2009;181:1140.
109. Eisner BH, Eisenberg ML, Stoller ML. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis. J Urol. 2009;182:2330-3.
110. Yun SJ, Ha YS, Kim WT, et al. Sodium restriction as initial conservative treatment for urinary stone disease. J Urol. 2010; 184:1372-6.
111. Nouvenne A, Meschi T, Prati B, Guerra A, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010;91:565-70.
112. Thom JA, Morris JE, Bishop A, Blacklock NJ. The influence of refined carbohydrate on urinary calcium excretion. Br J Urol. 1978;50:459-64. (Pubitemid 9073859)
113. Iguchi M, Umekawa T, Takamura C, et al. Glucose metabolism in renal stone patients. Urol Int. 1993;51:185-90. (Pubitemid 23312872)
114. Power C, Barker DJ, Nelson M, Winter PD. Diet and renal stones: a case-control study. Br J Urol. 1984;56:456-9. (Pubitemid 14021664)
115. Knight J, Assimos DG, Easter L, Holmes RP. Metabolism of fructose to oxalate and glycolate. Hormone Metab Res. 2010; 42:868-73.
116. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143:240-7. (Pubitemid 26032629)
117. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128:534-40. (Pubitemid 28177660)
118. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839-43. (Pubitemid 26052660)
119. Honow R, Laube N, Schneider A, Kessler T, Hesse A. Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization. Br J Nutr. 2003;90:295-300. (Pubitemid 36992530)
120. Trinchieri A, Lizzano R, Bernardini P, et al. Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation. Dig Liver Dis. 2002;34(Suppl 2):S160-3.
121. Shuster J, Finlayson B, Scheaffer RL, Sierakowski R, Zoltek J, Dzegede S. Primary liquid intake and urinary stone disease. J Chron Dis. 1985;38:907-14. (Pubitemid 16195285)
122. Shuster J, Jenkins A, Logan C, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992;45:911-6.
123. Sweeney DD, Tomaszewski JJ, Ricchiuti DD, Averch T. Effect of carbohydrate-electrolyte sports beverages on urinary stone risk factors. J Urol. 2009;182:992-7.
124. Penniston KL, Steele TH, Nakada SY. Lemonade therapy increases urinary citrate and urine volumes in paitents with recurrent calcium oxalate stone formation. Urology. 2007;70:856-60. (Pubitemid 350192574)
125. Koff SG, Paquette EL, Cullen J, et al. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Urology. 2007;69:1013-6. (Pubitemid 46891572)
126. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol. 2006;1:1269-74.
127. Taylor EN, Stampfer MJ, Curhan GC. Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis. 2005;45:267-74. (Pubitemid 40431051)
128. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol. 1992; 147:1215-8.
129. Robitaille L, Marner OA, Miller WH Jr, et al. Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism. 2009;58:263-9.
130. Curhan GC, Willett W, Rimm E, Stampfer MJ. A prospective study of the intake of vitamin C and vitamin B6 and the risk of kidney stones in men. J Urol. 1996;155:1847-51. (Pubitemid 26144069)
131. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10:840-5. (Pubitemid 29149535)
132. Penniston KL, Jones AN, Nakada SY, Hansen KE. Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women. BJU Int. 2009;104:1512-6.
133. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958;48:10-8.
134. Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977;87:404-10. (Pubitemid 8217077)
135. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among men and women. Kidney Int. 2001;59:2290-8. (Pubitemid 32467623)
136. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Sem Nephrol. 2008;28:120-32. (Pubitemid 351400300)
137. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol. 2009;4:1980-7.
138. Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter for-migenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 2008;19:1197-203.
139. Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol. 2008;3:1453-60.
140. Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG. Urinary citrate and renal stone disease. CMAJ. 1989;141(3): 217-21. (Pubitemid 19195785)
141. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allo-purinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386-9. (Pubitemid 17055411)
142. Matiaga BR, Schaeffer AJ, Novak TE, Trock BJ. Epidemiologic insights into pediatric kidney stone disease. Urol Res. 2010;38:453-7.
143. Spivacow FR, Negri AL, del Valle EE, et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol. 2008;23:1129-33.
144. VanDervoort K, Wiesen J, Frank R, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177:2300-5. (Pubitemid 46726436)
145. Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010;157:32-137.
146. Kalorin CM, Zabinski A, Okpareke I, et al. Pediatric stone disease-does age matter? J Urol. 2009;181:2267-71.
147. Pietrow PK, Pope JCIV, Adams MC, et al. Clinical outcome of pediatric stone disease. J Urol. 2002;167:670-3. (Pubitemid 34074560)
148. DeFoor WR, Jackson E, Minevich E, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology. 2010;76:242-5.
149. Alaya A, Nouri A, Najjar MF. Changes in stone composition according to age and gender in Tunisian children. J Ped Urol. 2010;6:364-71.
150. Erbaqci A, Erbaqci B, Yilmaz M, et al. Pediatric urolithiasis- evaluation of risk factors in 95 children. Scand J Urol Nephrol. 2003;37:129-33. (Pubitemid 36535231)
151. Acar B, Inci Arakan F, Emeksiz S, Dallar Y. Risk factors for nephrolithiasis in children. World J Urol. 2008;26:627-30.
152. Schaeffer AJ, Feng Z, Trock BJ, et al. Medical comorbidities associated with pediatric stone disease. Urology. 2011;77:195-9.
153. Schwaderer AL, Cronin R, Mahan JD, Bates CM. Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol. 2008;23:2209-14.